Collegium Pharmaceutical ...

NASDAQ: COLL · Real-Time Price · USD
37.71
0.55 (1.48%)
At close: Aug 15, 2025, 3:59 PM
37.74
0.08%
After-hours: Aug 15, 2025, 04:34 PM EDT

Collegium Pharmaceutical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
43.89M 69.19M 88.59M 99.89M 93.29M 48.16M 9.02M -11.16M -29.36M -25M -42.84M -35.25M 42.79M 71.52M 103.51M 106.75M 41.96M
Depreciation & Amortization
185.82M 164.69M 143.64M 143.52M 146.41M 149.26M 156.9M 157.78M 157.58M 138.94M 113.05M 92.26M 71.32M 68.92M 68.77M 68.52M 68.29M
Stock-Based Compensation
36.45M 32.4M 31.81M 31.52M 28.58M 27.14M 25.8M 24.15M 22.77M 22.87M 22.12M 22.69M 23.51M 24.25M 25.55M 24.77M 23.84M
Other Working Capital
-253K 18.57M -6.02M 17.11M 31.9M 23.77M 32.2M -19.73M -27.57M -38.5M -22M 41.85M 24.65M 44.13M 22.43M -24.95M -14.36M
Other Non-Cash Items
38.8M 114M 114.02M 177.56M 81.27M 30.62M 31.53M 32.4M 33.14M 8.52M 7.02M 5.48M 3.57M 3.42M 5.2M 6.66M 8.32M
Deferred Income Tax
-22.94M -26.81M -17M -9.4M -6.52M -2.15M -2.89M 337K -2.4M -8.39M -22.33M -24.8M -84.08M -78.04M -63.03M -62.37M 280K
Change in Working Capital
6.72M 16.81M -2.1M -1.11M 40.98M 21.73M 47.38M 32.97M -4.52M -12.71M 17.08M 8.22M 565K 13.49M -50.07M -37.47M -21.51M
Operating Cash Flow
198.44M 204.98M 193.67M 276.69M 309.01M 274.75M 267.74M 236.49M 177.22M 124.23M 94.1M 68.59M 57.67M 103.56M 89.94M 106.86M 121.18M
Capital Expenditures
-1.88M -1.65M -1.25M -1.07M -853K -461K -1.24M -1.28M -1.69M -1.62M -1.2M -1.36M -1.62M -1.94M -2.91M -5.04M -6.55M
Cash Acquisitions
n/a n/a -35.66M -41.66M -41.66M -41.66M -6M n/a n/a -572.07M -572.07M -572.07M -572.07M n/a n/a n/a n/a
Purchase of Investments
-97.95M -111.17M -124.94M -124.09M -131.46M -92.35M -51.42M -41.66M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
88.06M 92.6M 92.63M 69.21M 43.55M 22M 6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-267.54M -285.1M -249.44M 24.1M -17.56M n/a -35.66M -41.66M n/a n/a n/a n/a n/a n/a -368.23M -368.23M -369.64M
Investing Cash Flow
-279.31M -287.76M -301.09M -55.95M -88.76M -70.81M -46.66M -42.95M -1.69M -573.69M -573.27M -573.43M -573.69M -1.94M -2.91M -5.04M -6.55M
Debt Repayment
37.21M 7.52M -22.17M -216.55M -183.77M -65.92M -45.09M -24.25M -2.98M 442.68M 455.18M 467.68M 480.18M -50M -50M -50M -50.77M
Common Stock Repurchased
-11.32M -24.2M -24.17M -122.87M -88.09M -82.96M -65.6M -22.02M -21.8M -13.86M -38.56M -47.66M -48.08M -51.79M -19.54M -4.26M -4.41M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-14.77M -13.99M -10.7M -10.76M -3.85M 740K 4.55M 4.02M 2.48M 6.28M 1.8M 1.69M 5.87M 6.82M 4.58M 5.27M 2.66M
Financial Cash Flow
-31.69M -60.6M -87.15M -331.59M -262.62M -140.18M -98.17M -34.01M -12.74M 436.72M 420.05M 424.79M 439.93M -89.3M -59.21M -44.73M -48.11M
Net Cash Flow
-111.52M -142.34M -193.53M -110.86M -42.37M 63.76M 122.91M 159.53M 162.78M -12.74M -59.12M -80.05M -76.09M 12.31M 27.82M 57.09M 66.51M
Free Cash Flow
196.56M 203.33M 192.43M 275.62M 308.16M 274.29M 266.5M 235.2M 175.53M 122.61M 92.91M 67.23M 56.05M 101.61M 87.03M 101.83M 114.63M